WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 35 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,260,678 | -29.8% | 589,102 | 0.0% | 25.95% | -32.2% |
| Q2 2023 | $1,796,761 | +17.3% | 589,102 | 0.0% | 38.27% | +7.3% |
| Q1 2023 | $1,531,665 | +26.8% | 589,102 | 0.0% | 35.68% | +9.1% |
| Q4 2022 | $1,207,659 | -54.5% | 589,102 | 0.0% | 32.70% | -18.4% |
| Q3 2022 | $2,657,000 | +10.3% | 589,102 | 0.0% | 40.05% | +20.5% |
| Q2 2022 | $2,409,000 | -7.1% | 589,102 | 0.0% | 33.24% | -1.3% |
| Q1 2022 | $2,592,000 | -62.5% | 589,102 | +1.4% | 33.68% | -17.8% |
| Q4 2021 | $6,919,000 | -31.6% | 580,902 | -1.4% | 40.97% | +3.2% |
| Q3 2021 | $10,109,000 | -1.6% | 589,102 | 0.0% | 39.69% | -18.7% |
| Q2 2021 | $10,274,000 | – | 589,102 | – | 48.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,531,665 | 35.68% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $11,138,847 | 4.64% |
| MPM BioImpact LLC | 2,388,011 | $6,208,829 | 1.61% |
| RA Capital Management | 6,144,881 | $15,976,691 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,629,706 | 0.27% |
| PFM Health Sciences, LP | 2,217,220 | $5,764,772 | 0.26% |
| Rubric Capital Management LP | 1,935,357 | $5,031,928 | 0.13% |
| Laurion Capital Management LP | 522,900 | $1,359,540 | 0.01% |
| Alyeska Investment Group, L.P. | 397,808 | $1,034,301 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 81,711 | $212,449 | 0.01% |